CMH Wealth Management LLC raised its position in shares of Danaher Co. (NYSE:DHR) by 7.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 24,285 shares of the conglomerate’s stock after purchasing an additional 1,645 shares during the period. Danaher accounts for approximately 1.9% of CMH Wealth Management LLC’s holdings, making the stock its 17th biggest position. CMH Wealth Management LLC’s holdings in Danaher were worth $3,206,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. raised its position in shares of Danaher by 14.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,426,709 shares of the conglomerate’s stock worth $372,344,000 after buying an additional 424,317 shares in the last quarter. Martingale Asset Management L P raised its position in shares of Danaher by 0.6% during the 3rd quarter. Martingale Asset Management L P now owns 580,052 shares of the conglomerate’s stock worth $63,030,000 after buying an additional 3,402 shares in the last quarter. LPL Financial LLC raised its position in shares of Danaher by 17.8% during the 3rd quarter. LPL Financial LLC now owns 81,741 shares of the conglomerate’s stock worth $8,882,000 after buying an additional 12,337 shares in the last quarter. EP Wealth Advisors LLC bought a new stake in shares of Danaher during the 3rd quarter worth about $212,000. Finally, Point72 Asset Management L.P. raised its position in shares of Danaher by 1,243.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 268,700 shares of the conglomerate’s stock worth $29,197,000 after buying an additional 248,700 shares in the last quarter. 77.58% of the stock is owned by hedge funds and other institutional investors.
DHR stock traded down $1.65 during trading hours on Monday, hitting $129.98. The company’s stock had a trading volume of 1,596,387 shares, compared to its average volume of 2,547,479. The company has a quick ratio of 1.07, a current ratio of 1.47 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $94.21 billion, a price-to-earnings ratio of 28.76, a P/E/G ratio of 2.40 and a beta of 1.04. Danaher Co. has a 12 month low of $94.59 and a 12 month high of $134.50.
Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 29th. The conglomerate reported $1.28 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The company had revenue of $5.40 billion during the quarter, compared to the consensus estimate of $5.33 billion. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.19 earnings per share. On average, research analysts expect that Danaher Co. will post 4.79 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.52%. This is an increase from Danaher’s previous quarterly dividend of $0.16. The ex-dividend date is Thursday, March 28th. Danaher’s payout ratio is currently 15.04%.
A number of analysts have commented on the stock. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $147.00 price target on the stock in a research report on Tuesday, April 9th. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a $140.00 target price on shares of Danaher in a report on Monday, March 4th. Needham & Company LLC reiterated a “buy” rating and issued a $138.00 target price (up from $114.00) on shares of Danaher in a report on Thursday, February 28th. Jefferies Financial Group boosted their target price on shares of Danaher to $140.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. Finally, Deutsche Bank boosted their target price on shares of Danaher to $130.00 and gave the stock a “buy” rating in a report on Tuesday, February 26th. One equities research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $125.46.
In other Danaher news, CAO Robert S. Lutz sold 15,000 shares of the business’s stock in a transaction that occurred on Sunday, February 24th. The shares were sold at an average price of $127.00, for a total value of $1,905,000.00. Following the completion of the sale, the chief accounting officer now directly owns 22,251 shares of the company’s stock, valued at $2,825,877. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Walter G. Lohr sold 10,578 shares of the business’s stock in a transaction that occurred on Wednesday, February 27th. The stock was sold at an average price of $126.85, for a total transaction of $1,341,819.30. Following the completion of the sale, the director now directly owns 20,691 shares of the company’s stock, valued at $2,624,653.35. The disclosure for this sale can be found here. Insiders sold 183,150 shares of company stock valued at $23,279,637 over the last three months. Insiders own 11.90% of the company’s stock.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company’s Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
See Also: Mutual Funds
Receive News & Ratings for Danaher Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Danaher and related companies with MarketBeat.com’s FREE daily email newsletter.